Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Spec Pediatr Nurs. 2006 Apr;11(2):100-12; discussion 112-3.

Formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA): a critical review of the research.

Author information

  • 1Brigham Young University-Nursing, Provo, UT, USA.

Abstract

PURPOSE:

To summarize results of randomized controlled trials (RCTs) evaluating growth, cognitive, neurological, and visual development of term infants supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA).

DESIGN AND METHODS:

The Boyack and Lookinland Methodological Quality Index (MQI) was used to evaluate data from RCTs identified from multiple data bases.

RESULTS:

Six of ten studies found the addition of DHA and ARA to have no significant effect on infant development.

PRACTICE IMPLICATIONS:

More expensive formula with endogenous DHA and ARA is not necessary. Results from longer studies currently underway will be beneficial.

PMID:
16635189
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing Icon for PubMed Health
    Loading ...
    Write to the Help Desk